Nature

Nature (nature)

Journal positioning

Nature is the world's most broadly read scientific weekly, published by Springer Nature. It publishes a tiny selection of primary research that represents a single, decisive conceptual or empirical advance of exceptional significance to scientists across disciplines — not just to specialists in the author's field. The readership spans biology, physics, chemistry, earth science, and beyond; every paper must therefore tell a compelling story to a scientifically literate non-specialist. Almost all manuscripts are desk-rejected by editors before reaching peer review because they do not clear the broad-significance bar.

This skill is a fit / venue-selection / re-framing tool. It does not replace the journal's current official submission guidelines. Before submitting, re-check the live author instructions on the Springer Nature site and the submission system.

When to trigger

• The author names Nature as the target venue.
• A manuscript represents a single, paradigm-shifting result and the author is deciding between Nature, Science, and Cell.
• A specialist paper needs radical re-framing into a one-sentence "why the world needs to know this now" advance.
• The author needs Nature's high-frequency desk-reject risks and credible alternative-venue routing before submitting.

Scope & topic fit

• Any field of natural science or clinical science, provided the result is exceptional by cross-disciplinary standards — not just top-of-field.
• Fundamental discoveries that open new research directions (new mechanism, new phenomenon, new paradigm), rather than the best current increment in an ongoing program.
• Technology breakthroughs (AI systems, materials, therapeutics) where performance or principle crosses a conceptual threshold visible to scientists outside the field.
• Results that directly reshape scientific understanding of a major open question (origin of structures, disease mechanism, planetary science, evolution).
• Cross-disciplinary findings that bridge two or more fields and are best received by a joint audience.

Method & evidence bar

• The central claim must be robustly supported and self-contained: controls, statistics, replication across conditions, and data quality must be unimpeachable, because Nature's post-publication scrutiny is intense.
• Reporting standards are strict: a Nature reporting summary (life sciences) covering statistics, randomization, blinding, sample sizes, and replication must accompany biological papers; equivalent rigor is expected in physical-science methods sections.
• Extended Data (up to 10 figures/tables) carries essential validation, freeing the main figures for the narrative advance.
• Data and code availability statements are mandatory; deposition in community-standard repositories is expected.
• For studies involving human participants: ethics approval, consent, pre-registration, and reporting-guideline compliance are required.

Structure & house style

• Articles are short (main text is tightly constrained — re-check current word limits); the paper must make its conceptual contribution clear in the opening two paragraphs without assuming deep specialist knowledge.
• The title and abstract must convey the advance to a broad scientist: frame the finding ("We show that X causes Y") not the method ("We used CRISPR to ...").
• Letters (legacy format) and Articles both carry a brief Methods section in the main text; detailed protocols go into Supplementary Information or Extended Data, not the body.
• A significance statement or editor-facing cover letter must articulate in plain language why this result matters beyond the immediate field — editors use this as the first triage filter.
• Figures are publication-quality and must stand alone with legends; Nature is a print+online journal with tight figure-count limits (re-check current limits).
• Supplementary Information is for secondary validation; moving core results to the SI to meet length limits is a common desk-reject trigger.

Official-submission checklist

• Before giving submission-ready advice, read ../../resources/source-basis.md and ../../resources/official-source-map.md; start from the official source anchors for this journal family, then cite the current journal-specific page you checked.
• Search the live site for "Nature author instructions" and follow the current Springer Nature version.
• Re-check current article-type options (Article, Letter if still active, Brief Communication), word/figure limits, abstract format, and Extended Data allowance.
• Re-check reporting summary requirements (life-sciences checklist; physical/earth-sciences equivalents), data/code deposition policy, and materials-availability statement.
• Re-check preprint policy, embargo policy, AI-use disclosure, competing-interests and funding disclosure.
• Re-check ethics/consent/registration requirements for human or vertebrate-animal studies.
• If the live official instructions conflict with this skill, the official instructions win.

Pre-submission self-check

• One sentence explaining why this result matters to scientists outside the immediate subfield — a biologist would ask "so what?" about a physics paper, and vice versa; that answer must be in paragraph one.
• The contribution is framed as a conceptual advance or new phenomenon, not as "the first study to use method X on system Y."
• The manuscript does not depend on prior field-specific jargon in the title, abstract, or opening paragraph.
• Extended Data carries all essential validation; the main figures tell the complete narrative with no gaps.
• Reporting summary, data/code availability, and ethics/consent documentation are complete before submission.
• The cover letter explicitly names the cross-disciplinary readership that will benefit.

Common desk-reject triggers

• Significance is specialist-level only: "important advance in field X" without a compelling reason for a broader scientist to care.
• The paper is the fifth study of its kind rather than a decisive, paradigm-opening result.
• Core results buried in Supplementary Information; the main figures alone do not tell the story.
• Methods section is inadequate for reproducibility; no reporting summary or incomplete statistics reporting.
• Framing is technical ("we develop a method for ...") rather than discovery-based ("we discover that ...").
• A result that belongs in a Nature portfolio journal (nature-genetics, nature-methods, nature-materials, nature-medicine) — appropriate specialization is not a weakness.

Re-routing decision

• Strong result, specialist framing or specialist audience → the appropriate Nature portfolio journal: nature-genetics, nature-methods, nature-cell-biology, nature-materials, nature-medicine, nature-physics, nature-chemistry, nature-neuroscience.
• Broad significance, AAAS context or US institutional framing → science.
• Solid, complete advance of broad-discipline interest, not exceptional → nature-communications, science-advances, or pnas.
• Cell-biology or molecular-mechanism advance with deep validation → cell.

Output format

[Fit] High / Medium / Low (one-line reason)
[Target] Nature
[Topic tags] <2–3 closest topics>
[Method/evidence] <does the result clear the broad cross-disciplinary significance bar?>
[Top risk] <the single most likely reason for rejection>
[Official items to re-check] <article type / word limit / reporting summary / Extended Data / data-code / ethics / embargo>
[Re-route suggestion] <if not a fit, a better-matched venue>